Claudio Anasetti, MD
Enriched profileEmeritus Member, Department of Blood & Marrow Transplantation and Cellular Immunotherapy · H. Lee Moffitt Cancer Center and Research Institute (Emeritus)
Claudio Anasetti is Emeritus Member, Department of Blood & Marrow Transplantation and Cellular Immunotherapy at H. Lee Moffitt Cancer Center and Research Institute (Emeritus). OpenAlex indexes 853 publications with 41,215 citations (h-index 107); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Medical Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Claudio Anasetti, MD, is Emeritus Member, Department of Blood & Marrow Transplantation and Cellular Immunotherapy at H. Lee Moffitt Cancer Center and Research Institute (Emeritus). The public record shows 853 publications with 41,215 citations (h-index 107), centered on Lymphoma, Multiple Myeloma, Breast Cancer. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 2 companies, 6 NIH-funded awards (2004–2019).
- Most recent indexed publication: 2023 · Clinical cancer research
- Top research focus: Lymphoma
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
- Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia</p>
Sponsor: Fred Hutchinson Cancer Center
Industry payments
Updated 27 Aug 2026
2 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Kite Pharma, Inc.Program year20258 payments
- Kite Pharma, Inc.Program year20248 payments
- Kite Pharma, Inc.Program year20233 payments
NIH funding
Updated 27 Aug 2026
6 NIH research awards on record, funded 2004–2019 per NIH RePORTER. The latest:
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/claudio-anasetti-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
onclive.com/authors/claudio-anasetti-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Claudio-Anasetti-38604327
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mqa-internet.doh.state.fl.us ↗
- Fellowship in Hematology and Medical Oncology
University of Washington/Fred Hutchinson Cancer Research Center (1983-1989), with Dr. E. Donnall Thomas
1989provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →biography.omicsonline.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →biography.omicsonline.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org ↗
- Founder/launched the Immune Cell Therapy Program at Moffitt Cancer Center (2015)
instrumental in clinical development leading to FDA approval of the first CD19-specific CAR T-cell therapy for relapsed/refractory …
2015provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →biography.omicsonline.org ↗
Media & interviews
press, podcasts and appearances- OncLive video interview: "Dr. Anasetti Discusses the Trade-offs of BMT and PBSC"
discusses phase III trial comparing bone marrow transplant vs. peripheral blood stem cell transplant from unrelated donors
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Seth Steinberg, PhD
National Cancer Institute (NCI)
Gilles Salles
Memorial Sloan Kettering Cancer Center
Wyndham Wilson, MD
National Cancer Institute (NCI)
Julie Vose, MD
University of Nebraska Medical Center